What is the likely cause of elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in a patient who underwent cholecystectomy with common bile duct (CBD) stenting and subsequent stent removal?

Elevated Transaminases Post-CBD Stent Removal

The most likely causes of elevated AST (308) and ALT (140) after CBD stent removal are residual bile duct obstruction from retained stones or stricture, bile duct injury during the initial procedure, or cholangitis—all of which require urgent evaluation with imaging and consideration of repeat ERCP.

Immediate Diagnostic Considerations

The AST:ALT ratio of approximately 2:1 with AST predominance (308 vs 140) is particularly concerning in this post-procedural context and suggests:

Primary Concerns (Require Urgent Action)

Residual or recurrent CBD obstruction is the most critical consideration. The WSES guidelines emphasize that adequate biliary drainage must be ensured after stent removal 1. When stones are not completely extracted, short-term stenting followed by further intervention is strongly recommended 2. Your patient's enzyme pattern suggests:

• Retained CBD stones - The most common cause post-stent removal
• Bile duct stricture - Can develop at the stent site
• Cholangitis - Even without fever, biochemical cholangitis can occur

Bile duct injury from the original cholecystectomy or stenting procedure must be considered. BDIs occur in 0.4-1.5% of laparoscopic cholecystectomies and may present with delayed recognition 1. The WSES guidelines note that some BDIs are discovered later in the postoperative period, often translating to delayed or inappropriate treatment 1.

Secondary Considerations (Less Urgent but Important)

Transient post-procedural enzyme elevation - While research shows that transaminases commonly rise after laparoscopic cholecystectomy (ALT increases 2.2-fold in 82% of patients, AST 1.8-fold in 73% 3), these typically:

• Peak at 72 hours post-procedure 4
• Return to normal within 7-10 days 4
• Are attributed to pneumoperitoneum-induced hepatic ischemia 5

However, your patient is status post stent removal, not immediate post-cholecystectomy, making this explanation less likely unless the stent removal was very recent.

Algorithmic Approach to Diagnosis

Step 1: Timing Assessment

• If <7 days post-stent removal: Transient elevation possible but obstruction must be ruled out
• If >7 days post-stent removal: Obstruction or injury highly likely

Step 2: Clinical Evaluation

Look specifically for:

• Abdominal pain (especially RUQ)
• Fever or chills (cholangitis)
• Jaundice or dark urine
• Pruritus (suggests cholestasis)

Step 3: Additional Laboratory Tests

Obtain immediately:

• Total and direct bilirubin - Elevated suggests obstruction
• Alkaline phosphatase and GGT - Should be elevated if obstruction present
• Complete blood count - Leukocytosis suggests infection
• Coagulation studies - Assess synthetic liver function

Step 4: Imaging

Abdominal ultrasound first to assess:

• CBD diameter (normal <6mm, dilated suggests obstruction)
• Intrahepatic duct dilation
• Residual stones

If ultrasound shows obstruction or high clinical suspicion: Proceed directly to MRCP or repeat ERCP 2

Management Algorithm

If Obstruction Confirmed:

Repeat ERCP with stone extraction is the standard of care 2. The 2017 Gut guidelines strongly recommend that clearance of bile duct stones should be considered standard care, and stenting as definitive treatment should be restricted to patients with limited life expectancy or prohibitive surgical risk 2.

Options include:

• ERCP with balloon extraction or basket retrieval
• Mechanical lithotripsy if stones are large
• Cholangioscopy for difficult cases 2

If No Obstruction Found:

Consider:

• Bile duct stricture - May require balloon dilation or repeat stenting
• Occult bile leak - CT or HIDA scan may be needed
• Hepatocellular injury - Viral hepatitis, drug-induced liver injury

Critical Pitfalls to Avoid

1. Do not assume transient post-procedural elevation without imaging confirmation of patent biliary tree
2. Do not delay imaging - The AST level of 308 is significantly elevated and warrants urgent evaluation
3. Do not miss cholangitis - Can be present without classic Charcot's triad
4. Do not forget vascular injury - Right hepatic artery injury can accompany BDI and cause hepatocellular injury 1

Pattern Recognition

The AST > ALT pattern (2:1 ratio) in this context is atypical for simple post-procedural changes, which usually show ALT > AST 4, 3. This pattern raises concern for:

• More severe hepatocellular injury
• Possible ischemic component (vascular injury)
• Alcohol use (though less relevant in surgical context)

Bottom line: This patient needs urgent abdominal ultrasound and likely repeat ERCP to ensure adequate biliary drainage and rule out retained stones or stricture 2, 1.